Correlation Between Unicycive Therapeutics and ESSA Pharma
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and ESSA Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and ESSA Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and ESSA Pharma, you can compare the effects of market volatilities on Unicycive Therapeutics and ESSA Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of ESSA Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and ESSA Pharma.
Diversification Opportunities for Unicycive Therapeutics and ESSA Pharma
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Unicycive and ESSA is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and ESSA Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSA Pharma and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with ESSA Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSA Pharma has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and ESSA Pharma go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and ESSA Pharma
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.94 times more return on investment than ESSA Pharma. However, Unicycive Therapeutics is 1.07 times less risky than ESSA Pharma. It trades about 0.03 of its potential returns per unit of risk. ESSA Pharma is currently generating about -0.05 per unit of risk. If you would invest 78.00 in Unicycive Therapeutics on September 5, 2024 and sell it today you would lose (7.00) from holding Unicycive Therapeutics or give up 8.97% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.2% |
| Values | Daily Returns |
Unicycive Therapeutics vs. ESSA Pharma
Performance |
| Timeline |
| Unicycive Therapeutics |
| ESSA Pharma |
Unicycive Therapeutics and ESSA Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and ESSA Pharma
The main advantage of trading using opposite Unicycive Therapeutics and ESSA Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, ESSA Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will offset losses from the drop in ESSA Pharma's long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| ESSA Pharma vs. Candel Therapeutics | ESSA Pharma vs. Cingulate Warrants | ESSA Pharma vs. Unicycive Therapeutics | ESSA Pharma vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |